Drug Eluting Balloon Market - 2024-2031

August 2025 | 46 pages | ID: DD9D2A7ED762EN
DataM Intelligence

Abstracts

Drug Eluting Balloon Marketis is growing with a CAGR of 10.40% during the forecast period 2026-2035.

The Drug Eluting Balloon Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Drug Eluting Balloon Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product Type

• Coronary Drug Eluting Balloon*
• Peripheral Drug Eluting Balloon
• Others

By End-Users

• Hospitals*
• Cardiac Catheterization Laboratories
• Ambulatory Surgery Centers
• Others

Regional Analysis for Drug Eluting Balloon Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Drug Eluting Balloon Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Market Snippet by Product Type
3.2.Market Snippet by Drug Coating Technology
3.3.Market Snippet by End-Users

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1.Drivers
  4.1.2.Restraints
  4.1.3.Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1.Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis

6. BY PRODUCT TYPE

6.1. Introduction
6.2.Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type Segment
6.3.Market Attractiveness Index, By Product Type Segment
  6.3.1. Coronary Drug Eluting Balloon*
    6.3.1.1.Introduction
    6.3.1.2.Market Size Analysis, and Y-o-Y Growth Analysis (%)
  6.3.2. Peripheral Drug Eluting Balloon
  6.3.3. Others

7. PERIPHERAL DRUG ELUTING BALLOON

7.1. Introduction
7.2.Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Coating Technology Segment
7.3.Market Attractiveness Index, By Drug Coating Technology Segment
  7.3.1. Paccocath*
    7.3.1.1.Introduction
    7.3.1.2.Market Size Analysis, and Y-o-Y Growth Analysis (%)
  7.3.2. FreePac
  7.3.3. TransPax
  7.3.4. EnduraCoat
  7.3.5. Others

8. BY END-USERS

8.1.Introduction
8.2.Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users Segment
8.3. Market Attractiveness Index, By End-Users Segment
  8.3.1. Hospitals*
    8.3.1.1.Introduction
    8.3.1.2.Market Size Analysis, and Y-o-Y Growth Analysis (%)
  8.3.2. Cardiac Catheterization Laboratories
  8.3.3. Ambulatory Surgery Centers
  8.3.4. Others

9. BY REGION

9.1. Introduction
  9.1.1.Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  9.1.2. Market Attractiveness Index, By Region
9.2.North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Coating Technology
  9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
  9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.2.6.1.U.S.
    9.2.6.2.Canada
    9.2.6.3.Mexico
9.3.Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Coating Technology
  9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
  9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.3.6.1.Germany
    9.3.6.2.U.K.
    9.3.6.3.France
    9.3.6.4.Italy
    9.3.6.5.Spain
    9.3.6.6.Rest of Europe
9.4.South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Coating Technology
  9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
  9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.4.6.1.Brazil
    9.4.6.2. Argentina
    9.4.6.3.Rest of South America
9.5.Asia Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Coating Technology
  9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users
  9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    9.5.6.1.China
    9.5.6.2.India
    9.5.6.3.Japan
    9.5.6.4.Australia
    9.5.6.5.Rest of Asia Pacific
9.6.Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Coating Technology
  9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-Users

10. COMPETITIVE LANDSCAPE

10.1.Competitive Scenario
10.2.Market Positioning/Share Analysis
10.3.ergers and Acquisitions Analysis

11. COMPANY PROFILES

11.1.Becton, Dickinson and Company (BD)*
  11.1.1. Company Overview
  11.1.2.Product Portfolio and Description
  11.1.3.Key Highlights
  11.1.4. Financial Overview
11.2.Medtronic
11.3.Boston Scientific Corporation
11.4.Cook Medical
11.5.B. Braun Melsungen AG
11.6.Koninklijke Philips N.V.
11.7.Opto Circuits (India) Limited
11.8.Surmodics, Inc
11.9.Biotronik
11.10.Acotec Scientific

12. DATAM INTELLIGENCE

12.1.Appendix
12.2.About Us and Services
12.3. Contact Us